Skip to Main Content
CWRU Links
Case Comprehensive Cancer Center

2017 Cancer Center News

2017 Cancer Center News

National Experts Map out Adolescent and Young Adult Cancer Research Agenda

Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine are focusing their efforts on adolescent and young adult (AYA) cancer research. More than 50 leaders from top cancer research institutions will gather this Friday, Dec. 8, in Atlanta to identify a strategic plan for combating AYA cancer for the next three to five years. more>

American Society of Hematology Annual Meeting 2017

The American Society of Hematology (ASH) will hold its annual meeting December 9-12, 2017 in Atlanta, GA. This meeting highlights science in malignant and non-malignant hematology. We have strong representation from the Case CCC, with many members and trainees attending, leading sessions and presenting. Best of luck to all participants! 
View list of Case Comprehensive Cancer Center presentations [ASH Annual Meeting 2017]. 

San Antonio Breast Cancer Symposium 2017

The first week in December 2017, researchers and health professionals will come together for the San Antonio Breast Cancer Symposium. The event provides a forum to discuss basic, clinical and translational research, and advance progress against breast cancer. 
View list of Case Comprehensive Cancer Center presentations [San Antonio Breast Cancer Symposium 2017‌]. 

Case Western Reserve University Receives $6 Million to Study Barrett’s Esophagus

The National Cancer Institute recently awarded a $6 million grant to the Case Comprehensive Cancer Center and Case Western Reserve University School of Medicine to continue research on Barrett’s Esophagus, a potentially fatal condition caused by long-term acid reflux. The highly competitive five-year award provides resources to investigate genetic determinants of Barrett’s Esophagus and esophageal adenocarcinoma. more>

American Association for Cancer Research Annual Meeting 2017

The American Association for Cancer Research (AACR) will hold its annual meeting April 1-5, 2017 in Washington, DC. This meeting highlights the best cancer science and medicine world-wide, and we are excited to have many members and trainees participating.  Best of luck to all participants! 
View list of Case Comprehensive Cancer Center presentations [AACR-2017]. 

News from the NCI - Provocative Questions

The NCI's Provocative Questions (PQ) Initiative has assembled a list of 12 important, but non-obvious or understudied, questions based on input from the NCI's extramural research community to stimulate use of laboratory, clinical and population sciences in especially effective and imaginative ways to answer the questions. The current list of 12 PQs is updated from previous PQ Funding Opportunity Announcements (FOAs). more>

Case Comprehensive Cancer Center Researchers Receive Outstanding Investigator Awards from NIH

Three Case Comprehensive Cancer Center researchers received Outstanding Investigator Awards from the National Institutes of Health (NIH). These highly competitive multi-year federal grants recognize investigators who have achieved significant research accomplishments. The amount and duration of the awards allows researchers to take greater risks and be more adventurous in their research. more>

Case Comprehensive Cancer Center and nation's cancer centers jointly endorse updated HPV vaccine recommendations

Statement supports fewer vaccinations, urges action to increase national vaccination rates

Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), the Case Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC). [View full statement: HPV Consensus Statement - 2017jan11‌]

According to the CDC, incidence rates of HPV-associated cancers have continued to rise, with approximately 39,000 new HPV-associated cancers now diagnosed each year in the United States. Although HPV vaccines can prevent the majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers, vaccination rates remain low across the U.S., with just 41.9 percent of girls and 28.1 percent of boys completing the recommend vaccine series. more>